When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Rubéola

Última revisão: 21 Oct 2024
Última atualização: 03 Apr 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • exantema maculopapular
  • febre
  • artralgias
  • linfadenopatia
  • imunização incompleta
Detalhes completos

Outros fatores diagnósticos

  • mal-estar
  • coriza ou faringite
  • artrite
  • conjuntivite
Detalhes completos

Fatores de risco

  • imunização incompleta
  • exposição a contato infeccioso
  • viagem internacional
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • IgM anti-rubéola salivar
  • sorologia
  • Hemograma completo
Detalhes completos

Investigações a serem consideradas

  • cultura viral
  • reação em cadeia da polimerase via transcriptase reversa (RT-PCR)
Detalhes completos

Algoritmo de tratamento

Aguda

gestantes: suscetíveis e expostas à rubéola

não gestantes: rubéola sintomática

Colaboradores

Autores

Elisabeth Adderson, MD
Elisabeth Adderson

Associate Member

St. Jude Children's Research Hospital

Associate Professor of Pediatrics

University of Tennessee Health Sciences Center

Memphis

TN

Declarações

EA declares that she has no competing interests.

Revisores

Elizabeth Barnett, MD, FAAP

Director of International Clinical Maxwell Finland Laboratory for Infectious Diseases

Boston Medical Center

Associate Professor of Pediatrics

Boston University School of Medicine

Boston

MA

Declarações

EB has received research grant support from Sandipasteen and Intercell and received an honorarium to attend a meeting sponsored by Novartis. She receives royalties from the sale of a book she edited.

Suzanne M. Garland, MBBS, MD, FRCPAm FAChSHM, FRANZCOG ad eundem

Director of Microbiological Research

Head of Clinical Microbiology and Infectious Diseases

Royal Women's Hospital

Senior Consultant of Microbiology

Royal Children's Hospital

Professor

Faculty of Medicine, Dentistry and Health

Department of Obstetrics and Gynaecology

University of Melbourne

Melbourne

Australia

Declarações

SMG has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline, and lecture fees from Merck and GSK. SMG has received funding through her institution to conduct HPV vaccine studies for MSD and GSK.

Robert S. Duszak, OD, FAAO

Co-Director of Residency Program and Consulting Staff

Philadelphia Veterans Affairs Medical Center

Consulting Staff

Nemours Health Clinic & Mayfair Eye Associates

Adjunct Clinical Faculty

Pennsylvania College of Optometry

Salus University

Philadelphia

PA

Declarações

RSD declares that he has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal